U.S. markets closed
  • S&P 500

    4,185.47
    +15.05 (+0.36%)
     
  • Dow 30

    34,200.67
    +164.68 (+0.48%)
     
  • Nasdaq

    14,052.34
    +13.58 (+0.10%)
     
  • Russell 2000

    2,262.67
    +5.60 (+0.25%)
     
  • Crude Oil

    63.07
    -0.39 (-0.61%)
     
  • Gold

    1,777.30
    +10.50 (+0.59%)
     
  • Silver

    26.04
    +0.08 (+0.29%)
     
  • EUR/USD

    1.1980
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.5730
    +0.0430 (+2.81%)
     
  • GBP/USD

    1.3840
    +0.0056 (+0.41%)
     
  • USD/JPY

    108.7830
    +0.0670 (+0.06%)
     
  • BTC-USD

    56,931.77
    -5,304.96 (-8.52%)
     
  • CMC Crypto 200

    1,398.97
    +7.26 (+0.52%)
     
  • FTSE 100

    7,019.53
    +36.03 (+0.52%)
     
  • Nikkei 225

    29,683.37
    +40.68 (+0.14%)
     

Health Catalyst Inc (HCAT) CEO Daniel D. Burton Sold $3.7 million of Shares

GuruFocus.com
·3 min read

- By insider

CEO of Health Catalyst Inc (30-Year Financial, Insider Trades) Daniel D. Burton (insider trades) sold 121,052 shares of HCAT on 08/25/2020 at an average price of $30.39 a share. The total sale was $3.7 million.


Health Catalyst Inc has a market cap of $1.22 billion; its shares were traded at around $30.73 with and P/S ratio of 6.25. GuruFocus has detected 1 severe warning sign with Health Catalyst Inc. .

CEO Recent Trades:

  • CEO Daniel D. Burton sold 121,052 shares of HCAT stock on 08/25/2020 at the average price of $30.39. The price of the stock has increased by 1.12% since.

  • CEO Daniel D. Burton sold 122,868 shares of HCAT stock on 08/21/2020 at the average price of $32.22. The price of the stock has decreased by 4.62% since.

  • CEO Daniel D. Burton sold 149,687 shares of HCAT stock on 08/19/2020 at the average price of $32.52. The price of the stock has decreased by 5.5% since.

  • CEO Daniel D. Burton sold 171,612 shares of HCAT stock on 08/17/2020 at the average price of $31.82. The price of the stock has decreased by 3.43% since.

  • CEO Daniel D. Burton sold 200,570 shares of HCAT stock on 07/31/2020 at the average price of $35.37. The price of the stock has decreased by 13.12% since.

CFO Recent Trades:

  • CFO James Patrick Jr. Nelli sold 64,547 shares of HCAT stock on 08/17/2020 at the average price of $31.69. The price of the stock has decreased by 3.03% since.

Directors and Officers Recent Trades:

  • General Counsel Daniel H. Orenstein sold 5,000 shares of HCAT stock on 08/14/2020 at the average price of $31.45. The price of the stock has decreased by 2.29% since.

  • Director Anita Pramoda sold 4,000 shares of HCAT stock on 08/14/2020 at the average price of $31.46. The price of the stock has decreased by 2.32% since.

  • COO Paul Horstmeier sold 10,800 shares of HCAT stock on 08/03/2020 at the average price of $35.51. The price of the stock has decreased by 13.46% since.

  • Chief People Officer Linda Llewelyn sold 2,242 shares of HCAT stock on 08/03/2020 at the average price of $35.46. The price of the stock has decreased by 13.34% since.

  • Chief Technology Officer Dale Sanders sold 27,500 shares of HCAT stock on 08/03/2020 at the average price of $35.52. The price of the stock has decreased by 13.49% since.

For the complete insider trading history of HCAT, click here

.This article first appeared on GuruFocus.